KFA
BSX icon

Krane Funds Advisors’s Boston Scientific BSX Stock Holding History

Krane Funds Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
19,900
+4,000
+25% +$320K 0.05% 92
2025
Q4 		$1.52M Buy
+15,900
New +$1.56M 0.05% 59

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Krane Funds Advisors's BSX Position: Q1 2026 in Review

Krane Funds Advisors increased its Boston Scientific (BSX) stake by 25% in Q1 2026, buying an estimated $320K and bringing the position to 19,900 shares worth $1.24M. The position accounts for 0.05% of the portfolio, ranked #92.

Krane Funds Advisors first reported a position in BSX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.52M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Krane Funds Advisors held 19,900 shares of Boston Scientific worth $1.24M as of Q1 2026.
  • Krane Funds Advisors bought 4,000 Boston Scientific shares in Q1 2026, an estimated $320K.
  • Boston Scientific made up 0.05% of Krane Funds Advisors's portfolio in Q1 2026, its #92 holding.
  • Krane Funds Advisors first reported a position in Boston Scientific in Q4 2025 and has held it in 2 quarters since.
  • Krane Funds Advisors's Boston Scientific position peaked at $1.52M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Krane Funds Advisors's 13F filing for Q1 2026, filed 11 May 2026.